Immunoglobulins with reduced aggregation

Details for Australian Patent Application No. 2009259901 (hide)

Owner Novartis AG Massachusetts Institute of Technology

Inventors Helk, Bernhard; Kayser, Veysel; Trout, Bernhardt; Voynov, Vladimir; Chennamsetty, Naresh

Agent FB Rice

Pub. Number AU-A-2009259901

PCT Pub. Number WO2009/155513

Priority 61/151,368 10.02.09 US; 61/074,466 20.06.08 US

Filing date 19 June 2009

Wipo publication date 23 December 2009

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/155513 Priority application(s): WO2009/155513

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259904-Systems, apparatuses, and methods for providing non-transcranial electrotherapy

2009259893-Microvesicle-based compositions and methods